Super Bet richtet sein Angebot klar auf Spieler in Deutschland aus und setzt dabei konsequent auf Mobile First. Für Einsteiger ist wichtig zu verstehen, wie die App‑Mechanik, die getrennten Wallets für Sportwetten und Slots, sowie die deutschen Regulierungen den Alltag
Mrgreen is a long-standing international casino brand with a polished presentation and a multi-provider game lobby. For Canadians deciding whether the site fits their expectations, the practical questions are licensing, payment options (Interac matters here), game mix, mobile experience, and
Spin es una marca con trayectoria que llegó al mercado online como evolución de Spin Palace; para jugadores en Chile representa una opción clásica de casino con énfasis en tragamonedas de catálogo tradicional y pozos progresivos. En esta reseña práctica
Vavada ist für viele Spieler aus Deutschland eine bekannte Offshore-Option: große Spielauswahl, hohe Limits und schnelle Krypto-Auszahlungen. Gleichzeitig bringt genau diese Struktur spezifische Risiken und Mechaniken mit sich, die insbesondere Einsteiger verstehen sollten, bevor sie ein Konto eröffnen oder einzahlen.
This is a validation post. Time: 2026-05-05 09:23:46
The post Validation Check 2026-05-05 09:23:46 appeared first on .
The Third Circuit Court of Appeals affirmed on July 27, 2023, that infringement-suit defense costs for ANDA filers who file Paragraph IV certifications are deductible legal expenses, not capital expenditures to obtain FDA approval. The Court of Appeals noted that
[1] See our previous post on this case for a description of the arguments made on either side of the issue.
Recently, a unanimous Supreme Court issued its ruling in Amgen Inc. v. Sanofi, holding that Amgen’s challenged patents ran
In an opinion issued on March 6, 2023, the Federal Circuit affirmed the PTAB’s holding of unpatentability because the applications from which the patent claimed priority from lacked sufficient written description under 35 U.S.C. § 112. Regents of University of
Recently, the Federal Circuit affirmed the decision of the U.S. District Court for the District of Delaware granting a motion for an injunction to delist Jazz Pharmaceuticals, Inc.’s (“Jazz”) REMS patent from the Orange Book, as the patent covers neither
On Friday, February 10, 2023, the latest round of amicus briefs in Amgen Inc. v. Sanofi poured in. The case, set to be argued on March 27 before the U.S. Supreme Court, asks the Court to wrestle with the enablement
